Abstract
Magnetic iron oxide nanoparticles have attracted extensive interest as novel contrast agents for biomedical imaging owing to their capability of deep-tissue imaging, non-invasiveness and low toxicity. This mini-review will provide an overview on the recent synthesis methods, influencing factors and potential applications of magentic nanoparticles for cell labeling and imaging.
Keywords: Superparamagnetic iron oxide nanoparticles, magnetic nanoparticles, cell tracking, cytotoxicity, targeted imaging
Mini-Reviews in Medicinal Chemistry
Title: Recent Development and Application of Magnetic Nanoparticles for Cell Labeling and Imaging
Volume: 10 Issue: 3
Author(s): Chao Zhang, Tao Liu, Jining Gao, Yongping Su and Chunmeng Shi
Affiliation:
Keywords: Superparamagnetic iron oxide nanoparticles, magnetic nanoparticles, cell tracking, cytotoxicity, targeted imaging
Abstract: Magnetic iron oxide nanoparticles have attracted extensive interest as novel contrast agents for biomedical imaging owing to their capability of deep-tissue imaging, non-invasiveness and low toxicity. This mini-review will provide an overview on the recent synthesis methods, influencing factors and potential applications of magentic nanoparticles for cell labeling and imaging.
Export Options
About this article
Cite this article as:
Zhang Chao, Liu Tao, Gao Jining, Su Yongping and Shi Chunmeng, Recent Development and Application of Magnetic Nanoparticles for Cell Labeling and Imaging, Mini-Reviews in Medicinal Chemistry 2010; 10 (3) . https://dx.doi.org/10.2174/138955710791185073
DOI https://dx.doi.org/10.2174/138955710791185073 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science One-pot Synthesis and its Practical Application in Pharmaceutical Industry
Current Organic Synthesis Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings
Anti-Cancer Agents in Medicinal Chemistry Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy An Interventional Pulmonologist’s Tool: Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Thoracic Disease — An Update
Current Respiratory Medicine Reviews Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?
Current Drug Targets The Potential and Rationale for COX-2 Inhibitors in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Current Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Folate Receptor Targeted Liposomes
Drug Design Reviews - Online (Discontinued) Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy New Scope of Targeted Therapies in Lung Carcinoma
Mini-Reviews in Medicinal Chemistry